The biggest misconception in investing is that IPOs are where wealth is created, when in reality they are often where early wealth creation is simply revealed. By the time companies like SpaceX dominate public conversation, much of the asymmetric upside has already been absorbed in private markets long before retail investors ever see a ticker. Understanding how capital moves through private funding stages, narrative cycles, and eventual public listings is essential for recognizing where real opportunity is formed versus where it is simply redistributed.

Investors face a dilemma. When the S&P 500 finished its worst quarter since 2022 last month, diversifiers like bonds and bitcoin fell too.

Even with the turnaround in mid-April, analysts at Goldman Sachs and Vanguard have projected low-single-digit annualized returns from 2024-2034.

Bloomberg asked where experts would personally invest $100,000 for their March monthly edition.

One answer that surfaced for a second time? Art.

It's what billionaires like Bezos and the Rockefellers have privately used to diversify for decades.

Why?

Thanks to the world's premier art investing platform, now anyone can invest in works featuring legends like Banksy, Basquiat, and Picasso, without needing millions.

Shares in new offerings can sell quickly but...

Our subscribers skip their waitlist*

^{*According to Masterworks data. Investing involves risk. Past performance is not indicative of future returns. See important Reg A disclosures at masterworks.com/cd.}

In the full breakdown, we explore how private markets quietly shape the biggest winners in space, AI, and biotech—and why the most important investing edge today is not access to IPOs, but understanding what happens years before they ever arrive.

Let’s embark on this transformative journey together and position your portfolio for success in this evolving market landscape!

Be sure to read through to the end to catch all the valuable insights this newsletter delivers to your inbox today.

Picture this: Five years ago, AST SpaceMobile $ASTS ( ▲ 11.85% ) stock traded around $8 per share. Today in June 2026, it closes at $113.41 — an extraordinary +1,278% gain. The chart shows a long quiet period followed by a powerful surge, driven by progress in building a space-based cellular broadband network.

The 52-week high reached $133.86, showing the stock has already climbed significantly higher during strong phases. Keeping it simple: The compound annual growth rate (CAGR) over these five years is about 69%. If this pace continues, it means very powerful yearly gains that compound dramatically over time. Now imagine using dollar-cost averaging (DCA): adding $500 every month for the next five years.

This totals $30,000 invested from your pocket over 60 months. You buy more shares on dips and fewer on rises, which helps keep your average cost balanced.

If ASTS follows a similar historical pace around 69% annual growth, your monthly $500 contributions could grow your investment to approximately $148,000 by the end of five years. That means a gain of roughly $118,000 beyond what you put in — a remarkable return from consistent investing.

Past performance doesn't guarantee the future — satellite technology development, regulatory hurdles, or market shifts can change the path. But ASTS is pioneering direct-to-cell satellite connectivity with strong momentum. Your $500 monthly plan stays simple and easy to maintain, giving compounding plenty of room to deliver big potential.

The growing need for global mobile coverage keeps creating opportunities in this space. Staying disciplined through any temporary pullbacks is what usually leads to impressive long-term results.

Ready to reach for the stars with this kind of potential?

The anticipation around the eventual public listing of SpaceX has created a familiar pattern in markets: attention shifts to the headline, while the real value creation has already happened elsewhere.

By 2033, the restaurant robotics market’s projected to grow 3X. And Automated Retail Technologies has been front and center since 2021. To date, ART has 800+ robotic restaurant kiosks deployed across big-name partners like White Castle, Nestlé, Aramark, and more. White Castle alone just signed on for 1,000 more units. A Shark Tank investor already joined. Invest alongside him today for up to 10% bonus shares.

Invest in ART Today

^{This is a paid advertisement for Automated Retail Technologies Regulation CF offering. Please read the offering circular at https://invest.automatedrt.com/}

For most investors, the challenge is not awareness of the opportunity—it is timing. By the time a company reaches public markets, early-stage investors have already captured the most asymmetric part of the move. What remains is liquidity, volatility, and narrative-driven price discovery.

That structure is exactly why private investing has become such a dominant theme in modern capital markets.

Access to companies before IPO used to be limited to institutional investors, venture funds, and select accredited participants. However, private market platforms have expanded access significantly, allowing smaller investors to participate in earlier-stage funding rounds with relatively low minimums compared to historical standards.

Still, access alone does not solve the core problem: identifying which private companies are actually capable of scaling into meaningful public-market assets.

Within this landscape, a few case studies stand out because they illustrate how early-stage capital formation translates into public-market outcomes.

The most important insight is not that SpaceX will eventually list. It is that companies like it are already being built in parallel across aerospace, energy, and biotechnology sectors—and the earliest investors in those businesses are often capturing the majority of long-term upside before public markets even become aware.

Three private-market themes stand out from recent activity:

Each of these themes has already produced early winners, and each continues to attract capital before broader market visibility increases.

One of the most illustrative examples of early aerospace innovation is Starfighters Space $FJET ( ▼ 8.95% ), which is developing an unconventional hybrid launch system using modified fighter jets to deploy rockets at high altitude.

The core idea is not incremental improvement—it is structural cost reduction in orbital access.

Instead of relying solely on traditional rocket launches, the model involves taking decommissioned fighter jets, modifying them for high-altitude flight, and launching rockets from approximately 45,000 feet. This approach reduces atmospheric resistance and improves launch efficiency while potentially lowering cost per mission.

The strategic objective is clear:
Reduce launch timelines from months to weeks while lowering per-satellite deployment costs.

In a market where companies often wait six months or more for launch capacity, speed becomes a competitive advantage. Satellite operators increasingly prioritize flexible deployment windows, especially as demand for low Earth orbit infrastructure continues expanding.

Early private investors in Starfighters gained exposure at approximately the low single-digit range per share before the company transitioned into public trading dynamics through a direct listing structure. Initial trading volatility saw shares move significantly higher in the early sessions, reflecting the typical repricing that occurs when private-market valuations meet public-market liquidity.

The broader lesson is not the specific return profile, but the structural behavior:

Early-stage aerospace companies often reprice aggressively when liquidity arrives, especially when demand narratives already exist before listing.

However, what matters more for future investors is understanding that companies like Starfighters are attempting to solve a fundamental bottleneck in the space economy—launch accessibility.

That bottleneck is also why attention continues to build around larger private aerospace players like SpaceX, which dominate launch infrastructure but also highlight the scale of unmet demand across the sector.

A second major private-market theme emerging alongside aerospace is energy infrastructure, particularly nuclear-related supply chains.

One example is Eagle Nuclear Energy $UCLE ( ▲ 233.33% ), which focuses on uranium deposits in the United States, including a large resource base located near the Nevada–Oregon region.

The investment thesis behind this type of company is not short-term commodity speculation. It is based on structural demand shifts in energy consumption driven by data centers, artificial intelligence infrastructure, and long-term electrification trends.

Nuclear energy has re-emerged as a strategic priority in multiple countries due to its ability to provide stable, high-density power without the intermittency issues associated with renewables.

At the resource level, companies with verified uranium deposits represent upstream leverage to this trend. In Eagle Nuclear Energy’s case, estimated resource availability spans tens of millions of pounds of uranium equivalent, positioning it as a potential strategic supplier if nuclear expansion accelerates.

Private investors initially entered at approximately the low single-digit range before the company transitioned into public markets through a SPAC structure. Post-listing price action reflected both commodity-driven momentum and renewed interest in nuclear energy as a long-term infrastructure solution.

What makes this category particularly relevant is timing asymmetry.

Unlike aerospace, which is currently in the center of market attention, nuclear energy has experienced quieter sentiment periods. Historically, these quieter phases are where capital accumulation opportunities often form before broader re-rating cycles occur.

The underlying driver remains unchanged:
Energy demand growth is structurally outpacing current supply infrastructure.

That imbalance creates long-duration investment cycles rather than short-term trade opportunities.

A third private-market category attracting early-stage capital is biotechnology, where innovation cycles are driven by clinical development rather than market sentiment.

A notable example is Connectus Science $CNXU ( ▲ 19.26% ), which focuses on regenerative medical applications using human collagen-based biomaterials.

The company’s research direction includes wound healing technologies, tissue regeneration, and biomaterial scaffolding systems designed for surgical and reconstructive applications. More advanced research pathways include 3D tissue regeneration structures and biomaterial-based reconstruction applications.

Unlike aerospace or energy infrastructure, biotech operates under a fundamentally different risk model.

Progress is measured in clinical phases rather than revenue growth. Each stage of regulatory approval significantly alters valuation potential, but each stage also introduces binary risk outcomes.

Phase 1 clinical success often becomes a major inflection point, as it validates both scientific viability and commercial potential. However, failure at any stage can result in significant capital loss due to high development costs and regulatory uncertainty.

Early investors in Connectus Science entered at approximately the low-price private range before the company transitioned into public trading. Following listing, the stock experienced rapid repricing, reflecting both scientific optimism and speculative capital inflows typical of early biotech cycles.

This category consistently demonstrates one important truth:

Biotech investing is less about probability distribution and more about selective conviction in science, capital access, and execution capability.

Companies that successfully navigate early trials often become acquisition targets for larger pharmaceutical firms seeking to expand pipeline portfolios.

However, the majority of early-stage biotech companies fail to reach commercialization, making portfolio discipline essential in this segment.

Across aerospace, energy, and biotech, a consistent structural pattern emerges: early capital captures disproportionate upside before public markets assign valuation clarity.

This cycle is not random. It repeats across decades of market history.

Periods of elevated IPO activity often signal that private investors are beginning to realize gains and rotate capital into new opportunities. Meanwhile, public markets absorb those companies at significantly higher valuations than early private rounds.

Recent cycles have demonstrated this pattern clearly:

At the center of the current cycle sits SpaceX, which acts as both a symbol and catalyst for renewed attention toward private aerospace investing.

However, the most important insight is not about any single company.

It is about the structure of capital formation itself.

Private markets reward early risk-taking, but they also require patience, discipline, and selective allocation. Public markets reward liquidity, but often at the cost of reduced upside asymmetry.

The investors who consistently perform well across cycles tend to focus on three principles:

The space economy, nuclear energy resurgence, and biotech innovation all represent different expressions of the same underlying phenomenon: early-stage capital is increasingly shaping the industries that later define public-market performance.

The key distinction for any investor is not whether opportunities exist.

It is whether those opportunities are being evaluated before or after the crowd arrives.

And in cycles like the one forming now, that timing difference is where the most meaningful wealth creation continues to occur.

Ready to Revolutionize Your Wealth?

Here's what's waiting for you:

As the world becomes increasingly digital, this question will be on the minds of millions seeking new income streams in 2026.

The answer is—Absolutely!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every day. 

 What do you think of the new format? Please provide your feedback in the poll below, and if you find the newsletter valuable, feel free to share it with other investors!

Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Please consult with a financial advisor before making any investment decisions.